Dennis C. Shrieve, MD, PhD, is the Huntsman Cancer Institute Chair in Cancer Research and chair of the Department of Radiation Oncology at the University of Utah School of Medicine. He is a member of the Experimental Therapeutics Program at the Huntsman Cancer Institute and co-director of the Stereotactic Radiosurgery Program at the University.
Shrieve is board certified by the American Board of Radiology in Radiation Oncology and has primary clinical research interests in adult and pediatric neuro-oncology, pediatric radiation oncology, and stereotactic radiotherapy. His basic research interests include intrinsic radiosensitivity of human tumors, the mechanisms of intrinsic cellular resistance to radiation and chemotherapy, and combined chemotherapy/radiotherapy.
Shrieve serves on the Board of Trustees of the American Board of Radiology and is past-President of the International Stereotactic Radiosurgery Society. He has been listed in Best Doctors in America for over 10 years.
Shrieve received his MD from the University of Miami and his PhD in radiation biophysics from the University of California at Berkeley. He served on the faculties of the University of California, San Francisco, and Harvard Medical School before coming to the University of Utah.
Shrieve is the author or co-author of over 150 articles or book chapters in the medical and scientific literature. He co-editied the book "Human Radiation Injury" in 2010.
Clinical areas of special expertise include pediatric brain tumors, adult brain tumors, stereotactic radiosurgery and treatment of brain metastases.